Medical Edu., USF Morsani College of Medicine (MCOM), 12901 Bruce B Downs Blvd, Tampa, FL, USA.
Department of Surgery, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
World J Surg. 2019 Dec;43(12):3161-3171. doi: 10.1007/s00268-019-05118-4.
Significant numbers of patients in the USA and UK die while waiting for solid organ transplant. Only 1-2% of deaths are eligible as donors with a fraction of the deceased donating organs. The form of consent to donation may affect the organs available. Forms of consent include: opt-in, mandated choice, opt-out, and organ conscription. Opt-in and opt-out are commonly practiced. A systematic review was conducted to determine the effect of opt-in versus opt-out consent on the deceased donation rate (DDR) and deceased transplantation rate (DTR).
Literature searches of PubMed and EMBASE between 2006 and 2016 were performed. Research studies were selected based on certain inclusion criteria which include USA, UK, and Spain; compare opt-in versus opt-out; primary data analysis; and reported DDR or DTR. Modeled effect on US transplant activity was conducted using public data from Organ Procurement and Transplantation Network and Centers for Disease Control WONDER from 2006 to 2015.
A total of 2400 studies were screened and six studies were included. Four studies reported opt-out consent increases DDR by 21-76% over 5-14 years. These studies compared 13-25 opt-out countries versus 9-23 opt-in countries. Three studies reported opt-out consent increases DTR by 38-83% over 11-13 years. These studies compared 22-25 opt-out versus 22-28 opt-in countries. Modeled opt-out activity on the USA resulted in 4753-17,201 additional transplants annually.
Opt-out consent increases DDR and DTR and may be useful in decreasing deaths on the waiting list in the USA and other countries.
PROSPERO CRD42019098759.
在美国和英国,大量患者在等待实体器官移植时死亡。只有 1-2%的死亡符合捐赠者标准,而只有一小部分死者捐献器官。同意捐赠的形式可能会影响可获得的器官。同意的形式包括:选择加入、强制选择、选择退出和器官征募。选择加入和选择退出是常见的做法。进行了一项系统评价,以确定选择加入与选择退出同意对已故捐赠率(DDR)和已故移植率(DTR)的影响。
2006 年至 2016 年期间,对 PubMed 和 EMBASE 进行了文献检索。根据某些纳入标准选择研究,包括美国、英国和西班牙;比较选择加入与选择退出;进行了原发性数据分析;并报告了 DDR 或 DTR。使用 2006 年至 2015 年期间来自器官采购和移植网络以及疾病控制与预防中心 Wonder 的公共数据对美国移植活动的模型效果进行了研究。
共筛选了 2400 项研究,纳入了 6 项研究。四项研究报告称,选择退出同意在 5-14 年内将 DDR 提高了 21-76%。这些研究比较了 13-25 个选择退出国家与 9-23 个选择加入国家。三项研究报告称,选择退出同意在 11-13 年内将 DTR 提高了 38-83%。这些研究比较了 22-25 个选择退出国家与 22-28 个选择加入国家。对美国的模型化选择退出活动每年导致增加 4753-17201 例移植。
选择退出同意可以提高 DDR 和 DTR,并可能有助于减少美国和其他国家等待名单上的死亡人数。
PROSPERO CRD42019098759。